We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$19.5B
AUM Growth
+$5.19B
(+36%)
Cap. Flow
+$4.12B
Cap. Flow
% of AUM
21.08%
Top 10 Holdings %
Top 10 Hldgs %
20.25%
Holding
3,398
New
1,285
Increased
656
Reduced
281
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$224M |
| 2 |
PayPal
PYPL
|
+$220M |
| 3 |
Kroger
KR
|
+$154M |
| 4 |
Zillow
Z
|
+$133M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$189M |
| 2 |
Freeport-McMoran
FCX
|
+$176M |
| 3 |
AbbVie
ABBV
|
+$171M |
| 4 |
Booking.com
BKNG
|
+$155M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.46% |
| 2 | Healthcare | 11.27% |
| 3 | Materials | 10.17% |
| 4 | Technology | 7.72% |
| 5 | Consumer Discretionary | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PINC
151
DELISTED
Premier
PINC
| $19.4M | 0.1% |
555,101
+174,095
| +46% | +$5.8M |
|
152
Ironwood Pharmaceuticals
IRWD
$649M
| $19.2M | 0.1% |
1,550,044
+278,591
| +22% | +$3.16M |
|
153
MKS Inc
MKSI
$21.2B
| $18.8M | 0.1% |
+222,252
| New | +$17.8M |
|
154
Pacer Swan SOS Moderate October ETF
PSMO
$99.4M
| $18.8M | 0.1% |
898,989
-20,012
| -2% | -$415K |
|
155
Patrick Industries
PATK
$2.82B
| $18.5M | 0.09% |
+457,277
| New | +$15.9M |
|
156
Pacer Swan SOS Moderate July ETF
PSMJ
$92.4M
| $18.2M | 0.09% |
873,966
-19,180
| -2% | -$396K |
|
157
Teradata
TDC
$2.8B
| $17.9M | 0.09% |
531,227
+201,246
| +61% | +$6.47M |
|
158
Pacer Swan SOS Moderate January ETF
PSMD
$92.8M
| $17.4M | 0.09% |
789,910
-16,478
| -2% | -$355K |
|
159
Fulgent Genetics
FLGT
$556M
| $17.4M | 0.09% |
582,853
+95,645
| +20% | +$3.42M |
|
160
The GEO Group
GEO
$4.13B
| $17.3M | 0.09% |
+1,577,625
| New | +$15.3M |
|
161
Playtika
PLTK
$1.47B
| $16.4M | 0.08% |
1,930,258
+515,898
| +36% | +$4.78M |
|
162
Exelixis
EXEL
$14.1B
| $16.4M | 0.08% |
+1,021,248
| New | +$16.7M |
|
163
NETSCOUT
NTCT
$2.86B
| $16.2M | 0.08% |
498,900
+53,274
| +12% | +$1.84M |
|
164
Lumentum
LITE
$55.9B
| $16.2M | 0.08% |
310,428
+176,519
| +132% | +$10.8M |
|
165
Johnson & Johnson
JNJ
$643B
| $16.2M | 0.08% |
91,459
+81,343
| +804% | +$14M |
|
166
Takeda Pharmaceutical
TAK
$55.8B
| $16M | 0.08% |
1,026,297
-61,285
| -6% | -$856K |
|
167
Pacer Swan SOS Moderate April ETF
PSMR
$90.2M
| $16M | 0.08% |
748,526
-34,994
| -4% | -$738K |
|
168
Vodafone
VOD
$36.5B
| $15.9M | 0.08% |
1,570,882
+499,718
| +47% | +$5.61M |
|
169
Rambus
RMBS
$10.3B
| $15.9M | 0.08% |
442,672
+18,868
| +4% | +$638K |
|
170
Mondelez International
MDLZ
$77.8B
| $15.7M | 0.08% |
235,366
+166,224
| +240% | +$10.5M |
|
171
HUB Group
HUBG
$2.92B
| $15.6M | 0.08% |
391,872
+391,828
| +890,518% | +$15.3M |
|
172
LCI Industries
LCII
$2.53B
| $15.2M | 0.08% |
+164,144
| New | +$16.1M |
|
173
Amgen
AMGN
$203B
| $15.1M | 0.08% |
57,536
+37,730
| +190% | +$10.1M |
|
174
Cal-Maine
CALM
$4.22B
| $15M | 0.08% |
+274,721
| New | +$15.9M |
|
|
175
AbbVie
ABBV
$456B
| $14.9M | 0.08% |
92,407
-1,118,399
| -92% | -$171M |
|
Similar funds
SAM
Pacer Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Pacer Advisors held 3,398 positions worth $19.5B, up 36% from $14.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Pacer Advisors deployed $4.12B of net new capital in Q4 2022, opening 1,285 new positions and adding to 656 existing holdings. Its largest new stake was Woodside Energy: 805,273 shares worth $19.5M.
By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $189M trimmed.
- Pacer Advisors's largest Q4 2022 buy was Woodside Energy: 805,273 shares worth $19.5M.
- Pacer Advisors added most to EOG Resources in Q4 2022, an estimated $224M increase.
- Pacer Advisors's biggest Q4 2022 reduction was Regeneron Pharmaceuticals, cutting an estimated $189M.
- Pacer Advisors fully exited Rithm Capital in Q4 2022, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 20% of its $19.5B portfolio in Q4 2022.
- Pacer Advisors opened 1,285 new positions and closed 56 in Q4 2022.
- Pacer Advisors's portfolio value rose 36% quarter-over-quarter to $19.5B.
Based on Pacer Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.